2024-03-28T18:18:54Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_4987
2024-03-23T02:19:46Z
serval:BIB_4987
High frequency of marked hyperphosphatemia during intravenous calcitriol therapy in hemodialysis patients with refractory hyperparathyroidism.
10.1159/000170266
A1996UM17400003
8738537
Descombes
E.
author
Vogel
G.
author
Rosman
J.
author
Wauters
J.P.
author
article
1996
Blood purification
0253-5068
0253-5068
journal
14
3
234-241
Administration, Oral
Aged
Calcitriol/adverse effects
Calcitriol/therapeutic use
Female
Humans
Hyperparathyroidism, Secondary/drug therapy
Hyperparathyroidism, Secondary/etiology
Infusions, Intravenous
Male
Middle Aged
Phosphates/blood
Renal Dialysis/adverse effects
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish